The prevalence of NAFLD and NASH among patients with psoriasis in a tertiary care dermatology and rheumatology clinic

Alimentary Pharmacology and Therapeutics

Volumn 41, Issue 3, 2015, Pages 293-300

  Roberts, K K ^a   Cochet, A E ^a   Lamb, P B ^a   Brown, P J ^a   Battafarano, D F ^a   Brunt, E M ^b   Harrison, S A ^a  

^a SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HUMAN; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE; PSORIASIS; TERTIARY CARE CENTER; AGED; BIOPSY; COMPLICATION; FATTY LIVER; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OVERWEIGHT; QUESTIONNAIRE;

ADULT; AGED; BIOPSY; DIABETES MELLITUS; FATTY LIVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; OVERWEIGHT; PREVALENCE; PSORIASIS; QUESTIONNAIRES;

EID: 84920748217     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13042     Document Type: Article

References (18)

1. Nestle FO, Kaplan DH, Barker J,. Psoriasis. N Engl J Med 2009; 361: 496-509.
2. Wenk KS, Arrington KC, Ehrlich A,. Psoriasis and non-alcoholic fatty liver disease. J Eur Acad Dermatol Venereol 2011; 25: 383-91.
3. Gottlieb AB, Dann F,. Comorbidities in patients with psoriasis. Am J Med 2009; 122: 1150.
4. Johnsson H, McInnes IB, Sattar N,. Cardiovascular and metabolic risks in psoriasis and psoriatic arthritis: pragmatic clinical management based on available evidence. Ann Rheum Dis 2012; 71: 480-3.
5. Armstrong AW, Harskamp CT, Armstrong EJ,. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol 2013; 68: 654-62.
6. Madanagobalane S, Anandan S,. The increased prevalence of nonalcoholic fatty liver disease in psoriatic patients: a study from South India. Australas J Dermatol 2012; 53: 190-7.
7. Matsumoto T, Suzuki N, Watanabe H, et al,. Nonalcoholic steatohepatitis associated with psoriasis vulgaris. J Gastroenterol 2004; 39: 1102-5.
8. Gisondi P, Targher G, Zoppini G, Girolomoni G,. Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol 2009; 51: 758-64.
9. Miele L, Vallone S, Cefalo C, et al,. Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol 2009; 51: 778-86.
10. Gisondi P, Del Giglio M, Cozzi A,. Psoriasis, the liver, and the gastrointestinal tract. Dermatol Ther 2010; 23: 155-9.
11. Mehta NN, YiDing Y, Saboury B, et al,. Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT): a pilot study. Arch Dermatol 2011; 147: 1031-9.
12. Paredes AH, Torres DM, Harrison SA,. Nonalcoholic fatty liver disease. Clin Liver Dis 2012; 16: 397-419.
13. Vernon G, Baranova A, Younossi ZM,. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274-85.
14. Matteoni C, Younossi Z, Gramlich T, et al,. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-9.
15. Feldman SR, Krueger GG,. Psoriasis assessment tools in clinical trials. Ann Rheum Dis 2005; 64 (Suppl. II): ii65-8.
16. Kleiner DE, Brunt EM, Van Natta M, et al,. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-21.
17. Williams CD, Stengel J, Asike MI, et al,. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011; 140: 124-31.
18. van der Voort EA, Koehler EM, Dowlatshahi EA, et al,. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: results from a population-based study. J Am Acad Dermatol 2014; 70: 517-24.